These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 24768949)

  • 1. Identification of patients with increased immunological risk among potential kidney recipients in the Polish population.
    Moszkowska G; Zielińska H; Zieliński M; Dukat-Mazurek A; Dębska-Ślizień A; Rutkowski B; Lewandowska D; Danielewicz R; Trzonkowski P
    Hum Immunol; 2014 Jul; 75(7):650-5. PubMed ID: 24768949
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Algorithm to manage highly sensitized kidney transplant recipients in Poland.
    Zielińska H; Moszkowska G; Zieliński M; Debska-Ślizień A; Rutkowski B; Trzonkowski P
    Transplant Proc; 2011 Oct; 43(8):2903-7. PubMed ID: 21996185
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reappraisal of HLA antibody analysis and crossmatching in kidney transplantation.
    Lee PC; Ozawa M
    Clin Transpl; 2007; ():219-26. PubMed ID: 18642453
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Anti-HLA antibodies after bone graft and their impact on kidney transplant programs].
    Mosconi G; Baraldi O; Fantinati C; Cappuccilli ML; Corsini S; Zanelli P; Bassi A; Buscaroli B; Feliciangeli G; Stefoni S
    G Ital Nefrol; 2009; 26 Suppl 45():S58-63. PubMed ID: 19382096
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Consensus guidelines on the testing and clinical management issues associated with HLA and non-HLA antibodies in transplantation.
    Tait BD; Süsal C; Gebel HM; Nickerson PW; Zachary AA; Claas FH; Reed EF; Bray RA; Campbell P; Chapman JR; Coates PT; Colvin RB; Cozzi E; Doxiadis II; Fuggle SV; Gill J; Glotz D; Lachmann N; Mohanakumar T; Suciu-Foca N; Sumitran-Holgersson S; Tanabe K; Taylor CJ; Tyan DB; Webster A; Zeevi A; Opelz G
    Transplantation; 2013 Jan; 95(1):19-47. PubMed ID: 23238534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection and analysis of HLA class I and class II specific alloantibodies in the sera of dialysis recipients waiting for a renal retransplantation.
    Barocci S; Valente U; Nocera A
    Clin Transplant; 2007; 21(1):47-56. PubMed ID: 17302591
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Specific "intra-allele" and "intra-broad antigen" human leukocyte antigen alloantibodies in kidney graft transplantation.
    Muro M; González-Soriano MJ; Salgado G; López R; Boix F; López M; Campillo JA; Martínez P; Botella C; Gimeno L; Minguela A; Alvarez-López MR; Llorente S
    Hum Immunol; 2010 Sep; 71(9):857-60. PubMed ID: 20510320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Algorithms for the determination of unacceptable HLA antigen mismatches in kidney transplant recipients.
    Süsal C; Roelen DL; Fischer G; Campos EF; Gerbase-DeLima M; Hönger G; Schaub S; Lachmann N; Martorell J; Claas F
    Tissue Antigens; 2013 Aug; 82(2):83-92. PubMed ID: 23718733
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and specificity of immunoglobulin G and immunoglobulin A non-complement-binding anti-HLA alloantibodies in retransplant candidates.
    Arnold ML; Dechant M; Doxiadis II; Spriewald BM
    Tissue Antigens; 2008 Jul; 72(1):60-6. PubMed ID: 18588575
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pre- and posttransplant monitoring of alloantibodies by complement-dependent cytotoxicity and luminex methodologies in liver transplantation.
    Monteiro F; Rodrigues H; Kalil J; Castro MC; Panajotopoulos N; Paredes M; Massarolo P; Mies S
    Transplant Proc; 2012 Oct; 44(8):2411-2. PubMed ID: 23026608
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical relevance of HLA donor-specific antibodies detected by single antigen assay in kidney transplantation.
    Caro-Oleas JL; González-Escribano MF; González-Roncero FM; Acevedo-Calado MJ; Cabello-Chaves V; Gentil-Govantes MÁ; Núñez-Roldán A
    Nephrol Dial Transplant; 2012 Mar; 27(3):1231-8. PubMed ID: 21810767
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of donor-specific-antibodies by solid phase assay and its relevance to complement-dependent-lymphocytotoxicity cross-matching in kidney transplantation.
    Ho EK; Vasilescu ER; Vlad G; Clynes RA; Ratner LE; Suciu-Foca N
    Hum Immunol; 2014 Jun; 75(6):520-3. PubMed ID: 24662417
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Utility of HLAMatchmaker and single-antigen HLA-antibody detection beads for identification of acceptable mismatches in highly sensitized patients awaiting kidney transplantation.
    Goodman RS; Taylor CJ; O'Rourke CM; Lynch A; Bradley JA; Key T
    Transplantation; 2006 May; 81(9):1331-6. PubMed ID: 16699463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: are they relevant?
    Gupta A; Iveson V; Varagunam M; Bodger S; Sinnott P; Thuraisingham RC
    Transplantation; 2008 Apr; 85(8):1200-4. PubMed ID: 18431242
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Methodologies for anti-HLA antibody screening in patients awaiting kidney transplant: a comparative study.
    Minucci PB; Grimaldi V; Casamassimi A; Cacciatore F; Sommese L; Picascia A; Resse M; Sabia C; Russo A; Napoli C
    Exp Clin Transplant; 2011 Dec; 9(6):381-6. PubMed ID: 22142045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Low median fluorescence intensity could be a nonsafety concept of immunologic risk evaluation in patients with shared molecular eplets in kidney transplantation.
    Bosch A; Llorente S; Diaz JA; Salgado G; López M; Boix F; López-Hernández R; González-Soriano MJ; Campillo JA; Moya-Quiles MR; Perez-Lopez N; Minguela A; Jimeno L; Alvarez-López MR; Muro M
    Hum Immunol; 2012 May; 73(5):522-5. PubMed ID: 22425738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical relevance of human leukocyte antigen antibodies in kidney transplantation from deceased donors: the North Italy Transplant program approach.
    Poli F; Cardillo M; Scalamogna M
    Hum Immunol; 2009 Aug; 70(8):631-5. PubMed ID: 19527758
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Technical aspects of HLA antibody testing.
    Gebel HM; Liwski RS; Bray RA
    Curr Opin Organ Transplant; 2013 Aug; 18(4):455-62. PubMed ID: 23838651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Detection and specification of noncomplement binding anti-HLA alloantibodies.
    Arnold ML; Zacher T; Dechant M; Kalden JR; Doxiadis II; Spriewald BM
    Hum Immunol; 2004 Nov; 65(11):1288-96. PubMed ID: 15556679
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of human leukocyte antigen matching and recipients' panel reactive antibodies on two-year outcome in presensitized renal allograft recipients.
    Meng HL; Jin XB; Li XT; Wang HW; Lü JJ
    Chin Med J (Engl); 2009 Feb; 122(4):420-6. PubMed ID: 19302748
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.